ScinoPharm Taiwan, Ltd. announced that Yung-Fa Chen, Special Assistant to Chairman and Special Assistant to Chairman and Chief Technology Officer of the company has been replaced by Li-Chiao Chang, Vice President of Injectable Business Division and Chief Technology Officer and Vice President of Injectable Business Division of the company as Chief Technology Officer. The changes are effective August 1, 2018.
ScinoPharm Taiwan Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of active pharmaceutical ingredients. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The Company is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The Company operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.
SCINOPHARM TAIWAN, LTD. 
